Stay informed, stay ahead.
GSK, the major global pharmaceutical company, is on the brink of a significant victory. The company is expected to receive US Food and Drug Administration (FDA) approval for its new blood cancer treatment. A Boost for Patients This FDA approval marks a major win for patients battling blood cancer. The new treatment is likely targeted…
Novartis has announced strong results for its drug Fabhalta (iptacopan). The treatment slowed the progression of IgA nephropathy, a rare and serious kidney disease, in a major clinical trial. In the Phase III study, patients taking Fabhalta had a much slower loss of kidney function compared to those on placebo. The drug improved the eGFR…
Los Angeles — Amazon is expanding deeper into the healthcare sector with the launch of automated prescription vending kiosks at select One Medical clinics across the Los Angeles area. The machines, operated by Amazon Pharmacy, allow patients to pick up commonly prescribed medications directly on-site — a move that could reshape how consumers access basic…
